Ignite Creation Date:
2025-12-24 @ 5:22 PM
Ignite Modification Date:
2026-01-25 @ 12:16 PM
Study NCT ID:
NCT00433550
Status:
COMPLETED
Last Update Posted:
2017-08-24
First Post:
2007-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-08
First Submit QC Date:
None
Study First Post Date:
2007-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-15
Results First Submit QC Date:
None
Results First Post Date:
2017-08-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-25
Last Update Post Date:
2017-08-24
Last Update Post Date Type:
ACTUAL